Business Insights
Diagnostic Technologies
Diseases
Point-of-Care Testing
Research & Development
Sign In
Clinical Chemistry
Emerging Technology
Immunoassays
Molecular Diagnostics
Pathology & AI
Clinical Chemistry
Visiopharm, Boston Cell Standards team up to support higher assay requirements
By
Nick Paul Taylor
If the higher standards are enforced, the collaboration could help enable a revised approach to the regulation of IHC that is intended to increase standardization through the use of modern clinical laboratory quality assurance protocols.
August 17, 2023
Dr. Atul Butte calls for ‘new system of precision medicine’ in plenary lecture at AACC 2023
By
Nick Paul Taylor
The computer scientist told attendees how data-driven initiatives have transformed medical practice at the University of California health system, and how the combination of EHRs and AI could identify ways to cut the costs of treating patients.
July 31, 2023
Revvity launches automated workstation at AACC 2023 annual meeting
By
LabPulse.com staff writers
The workstation is a next-generation liquid handler that integrates technologies from Revvity’s existing platforms, designed to streamline workflows in next generation sequencing (NGS) and diagnostic research applications.
July 28, 2023
Novel catalyst unlocks new route to synthesis of medicines and advanced materials
By
Nick Paul Taylor
The field has lacked a method for consistently creating para-products via the Friedel−Crafts reaction. The Chiba University team addressed this unmet need by using a novel enzyme to modify the reaction to favor the generation of para-substituted products.
July 28, 2023
Physicians advocate for ‘careful’ use of osteoporosis bone turnover marker testing
By
Nick Paul Taylor
Knowing the rate of bone matrix removal or deposition can help physicians understand if a patient is at risk of fractures or is responding to treatment.
July 24, 2023
AACC announces name change ahead of Annual Scientific Meeting & Clinical Lab Expo
By
LabPulse.com staff writers
The name change, initiated by the board of directors, was approved in a member vote during spring.
July 18, 2023
Blood-based biomarker score suggests lower type 2 diabetes risk with Mediterranean diet
By
Elissa Wolfson
Researchers have developed a blood test to objectively detect adherence to a Mediterranean diet and its association with lower type 2 diabetes risk.
May 1, 2023
Quest launches long-COVID testing panels for consumers
By
LabPulse.com staff writers
The panels could be used by any of the millions of Americans that still suffer from lingering COVID-19 side effects, Quest said.
March 22, 2023
Siemens Healthineers, Unilabs ink 200-million euro agreement
By
LabPulse.com staff writers
In the first years of the agreement, Siemens Healthineers will install high- and mid-volume immunoassay and clinical chemistry analyzers, including the Atellica Solution and Atellica CI 1900, sample handlers, hemostasis analyzers, and automation solution
February 2, 2023
Abbott Q3 diagnostics revenues decline 6% on lower COVID testing demand
By
LabPulse.com staff writers
Excluding COVID-19 testing-related sales, worldwide Diagnostics sales declined 0.2% on a reported basis and increased 6.1% on an organic basis in the third quarter.
October 19, 2022
Roche Diagnostics revenues rise 4% for first nine months despite sharp drop in Q3 COVID sales
By
LabPulse.com staff writers
Roche posted CHF 600 million in Q3 revenues for COVID-19 products compared to CHF 1 billion in the same period last year.
October 18, 2022
QuidelOrtho expects Q3 revenues of $782 million to $785 million
By
LabPulse.com staff writers
For its first full quarter as a combined company, QuidelOrtho’s COVID-19 product revenue is expected to be approximately $171 million
October 12, 2022
Page 1 of 2
Next Page